EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $44,700 | -87.8% | 37,881 | -22.2% | 0.00% | -100.0% |
| Q3 2022 | $366,000 | +302.2% | 48,668 | +238.6% | 0.00% | +100.0% |
| Q2 2022 | $91,000 | -52.6% | 14,374 | -37.9% | 0.00% | 0.0% |
| Q1 2022 | $192,000 | +88.2% | 23,146 | +85.0% | 0.00% | 0.0% |
| Q3 2020 | $102,000 | -86.3% | 12,509 | -83.9% | 0.00% | -80.0% |
| Q2 2020 | $747,000 | +31.7% | 77,796 | -6.8% | 0.01% | 0.0% |
| Q1 2020 | $567,000 | +165.0% | 83,450 | +480.5% | 0.01% | +400.0% |
| Q4 2019 | $214,000 | – | 14,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |